Zosano Pharma Corporation (NASDAQ:ZSAN) has a beta value of 2.66 and has seen 12,631,470 shares traded in the last trading session. The company, currently valued at $54.36 Million, closed the last trade at $1 per share which meant it gained $0.05 on the day or 5.25% during that session. The ZSAN stock price is -221% off its 52-week high price of $3.21 and 59.5% above the 52-week low of $0.405. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.18 Million shares traded. The 3-month trading volume is 2.11 Million shares.
The consensus among analysts is that Zosano Pharma Corporation (ZSAN) is a Buy stock at the moment, with a recommendation rating of 1.7. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 3 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.14.
Zosano Pharma Corporation (NASDAQ:ZSAN) trade information
Sporting 5.25% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Friday, Jul 31 when the ZSAN stock price touched $1.09 or saw a rise of 8.26%. Year-to-date, Zosano Pharma Corporation shares have moved -34.21%, while the 5-day performance has seen it change 14.29%. Over the past 30 days, the shares of Zosano Pharma Corporation (NASDAQ:ZSAN) have changed 16.78%. Short interest in the company has seen 5.9 Million shares shorted with days to cover at 2.8.
Wall Street analysts have a consensus price target for the stock at $4.33, which means that the shares’ value could jump 333% from current levels. The projected low price target is $2 while the price target rests at a high of $7. In that case, then, we find that the current price level is +600% off the targeted high while a plunge would see the stock lose 100% from current levels.
Zosano Pharma Corporation (ZSAN) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +47.1% over the past 5 years. Earnings growth for 2020 is a modest +38.7%.